Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy

Nicola L. Diny, G. Christian Baldeviano, Monica V. Talor, Jobert G. Barin, Su Fey Ong, Djahida Bedja, Allison Hays, Nisha Gilotra, Isabelle Coppens, Noel R. Rose, Daniela Cihakova

Research output: Contribution to journalArticle


Inflammatory dilated cardiomyopathy (DCMi) is a major cause of heart failure in children and young adults. DCMi develops in up to 30% of myocarditis patients, but the mechanisms involved in disease progression are poorly understood. Patients with eosinophilia frequently develop cardiomyopathies. In this study, we used the experimental autoimmune myocarditis (EAM) model to determine the role of eosinophils in myocarditis and DCMi. Eosinophils were dispensable for myocarditis induction but were required for progression to DCMi. Eosinophil-deficient ΔdblGATA1 mice, in contrast to WT mice, showed no signs of heart failure by echocardiography. Induction of EAM in hypereosinophilic IL-5Tg mice resulted in eosinophilic myocarditis with severe ventricular and atrial inflammation, which progressed to severe DCMi. This was not a direct effect of IL-5, as IL-5TgΔdblGATA1 mice were protected from DCMi, whereas IL-5-/- mice exhibited DCMi comparable with WT mice. Eosinophils drove progression to DCMi through their production of IL-4. Our experiments showed eosinophils were the major IL-4-expressing cell type in the heart during EAM, IL-4-/- mice were protected from DCMi like ΔdblGATA1 mice, and eosinophil-specific IL-4 deletion resulted in improved heart function. In conclusion, eosinophils drive progression of myocarditis to DCMi, cause severe DCMi when present in large numbers, and mediate this process through IL-4.

Original languageEnglish (US)
Pages (from-to)943-957
Number of pages15
JournalJournal of Experimental Medicine
Issue number4
Publication statusPublished - Apr 1 2017


ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this